Replies to post #87512 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

I don't think we have to worry about $50 a share for a while. However, $5 a share could happen soon I hope.

Let's see how far the SP can move on:

A loan secured at reasonable terms.
A Cotara deal announced.
A blowout MOS announcement on the second line NSCLC trial.
A blowout MOS announcement on the first line NSCLC trial.
Solid results in the sorafenib-Bavi liver trial.
Solid results in the imaging trial.
Solid results in the pancreatic cancer trial.

If these move us past $5 a share, I'll start looking for $10 a share. A giant leap to $50 would be dandy, but one solid step at a time in that direction would be just fine by me.

Paul